New Ambu CEO might have to hunt for more capital, says media
Britt Meelby Jensen might have to raise millions of kroner from the stock exchange if medtech firm Ambu wants to stay on top of its efforts within gastroenterology.
by christian bundgaard, translated by daniel pedersen
According to Danish business daily Børsen, Ambu’s new chief executive, Britt Meelby Jensen, might find it necessary to seek capital from the stock exchange if the firm’s current growth strategy is meant to stay on tracks.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu recalls single-use product one year after launch
For subscribers
Britt Meelby Jensen wants to rebuild trust in Ambu
For subscribers
Outgoing Ambu CEO commends colleagues
For subscribers
